101 related articles for article (PubMed ID: 1861537)
1. Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential.
Hicsonmez G; Ozsoylu S; Tuncer AM
Leuk Res; 1991; 15(7):537-41. PubMed ID: 1861537
[No Abstract] [Full Text] [Related]
2. Direct morphological evidence of high-dose methylprednisolone-induced maturation of leukemic cells in children with acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S; Tuncer AM; Ertürk G; Ozbek N; Karadeniz N
Exp Hematol; 1991 Mar; 19(3):232-3. PubMed ID: 1995314
[No Abstract] [Full Text] [Related]
3. The role of short course of high-dose methylprednisolone in children with acute myeloblastic leukemia (FAB M2) presented with myeloid tumor.
Hiçsönmez G; Cetin M; Aslan D; Ozyürek E
Pediatr Hematol Oncol; 2003; 20(5):373-9. PubMed ID: 12775535
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of leukemic cells induced by short-course high-dose methylprednisolone in children with different subtypes of acute myeloblastic leukemia.
Hiçsönmez G; Tuncer M; Toksoy HB; Yenicesu I; Cetin M
Leuk Lymphoma; 1999 May; 33(5-6):573-80. PubMed ID: 10342585
[TBL] [Abstract][Full Text] [Related]
5. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis.
Hiçsönmez G
Leuk Res; 2006 Jan; 30(1):60-8. PubMed ID: 15979702
[TBL] [Abstract][Full Text] [Related]
6. Effects of methylprednisolone on human myeloid leukemic cells in vitro.
Ozbek N; Erdemli E; Hiçsönmez G; Okur H; Tekelioğlu M
Am J Hematol; 1999 Apr; 60(4):255-9. PubMed ID: 10203097
[TBL] [Abstract][Full Text] [Related]
7. High-dose methylprednisolone for acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S
Exp Hematol; 1989 Nov; 17(10):1051-2. PubMed ID: 2806437
[No Abstract] [Full Text] [Related]
8. Successful use of short-course high-dose methylprednisolone in a child with acute myeloblastic leukemia (FAB M2) and myeloid tumor.
Ozyurek E; Alioglu B; Coskun M; Ozbek N
Leuk Lymphoma; 2006 May; 47(5):923-5. PubMed ID: 16753881
[No Abstract] [Full Text] [Related]
9. Lovastatin induces a pronounced differentiation response in acute myeloid leukemias.
Dimitroulakos J; Thai S; Wasfy GH; Hedley DW; Minden MD; Penn LZ
Leuk Lymphoma; 2000 Dec; 40(1-2):167-78. PubMed ID: 11426618
[TBL] [Abstract][Full Text] [Related]
10. High-dose methylprednisolone in children with acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S
Am J Hematol; 1990 Dec; 35(4):288-9. PubMed ID: 2239928
[No Abstract] [Full Text] [Related]
11. The effect of high-dose methylprednisolone treatment on GM-CSF level in children with acute leukemia: a pilot study.
Tuncer AM; Hicsonmez G; Erturk G; Gumruk F; Albayrak D; Oguz H
Leuk Res; 1992; 16(6-7):615-9. PubMed ID: 1635379
[TBL] [Abstract][Full Text] [Related]
12. Circumvention of glucocorticoid resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
[TBL] [Abstract][Full Text] [Related]
13. [Differentiation induction of myeloid leukemia cells by glucocorticoid--the differentiation induction effect in vitro and in vivo].
Nakamaki T; Sakashita A; Sano M; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1989 Feb; 30(2):149-57. PubMed ID: 2746870
[TBL] [Abstract][Full Text] [Related]
14. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro.
Katagiri T; Miyazawa K; Nishimaki J; Yaguchi M; Kawanishi Y; Ohyashiki K
Leuk Lymphoma; 2000 Sep; 39(1-2):173-84. PubMed ID: 10975397
[TBL] [Abstract][Full Text] [Related]
15. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
[TBL] [Abstract][Full Text] [Related]
16. Geranylgeranylacetone used as an antiulcer agent is a potent inducer of differentiation of various human myeloid leukemia cell lines.
Sakai I; Tanaka T; Osawa S; Hashimoto S; Nakaya K
Biochem Biophys Res Commun; 1993 Mar; 191(3):873-9. PubMed ID: 8466527
[TBL] [Abstract][Full Text] [Related]
17. The smoldering myeloid leukemic states: clinical and biologic features.
Greenberg PL
Blood; 1983 Jun; 61(6):1035-44. PubMed ID: 6340754
[No Abstract] [Full Text] [Related]
18. Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia.
Elmas SA; Cetin M; Tuncer M; Hiçsönmez G
Am J Hematol; 2005 Sep; 80(1):1-5. PubMed ID: 16138333
[TBL] [Abstract][Full Text] [Related]
19. Morphologic evidence of apoptosis in childhood acute myeloblastic leukemia treated with high-dose methylprednisolone.
Hiçsönmez G; Erdemli E; Tekelioglu M; Tuncer AM; Ozbek N; Cetin M; Cotter TG
Leuk Lymphoma; 1996 Jun; 22(1-2):91-6,follow.186,color plate VII-III. PubMed ID: 8724533
[TBL] [Abstract][Full Text] [Related]
20. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
